Status:

NO_LONGER_AVAILABLE

Individual Patient Expanded Access IND to Treat Polyneuropathy

Lead Sponsor:

Hope Biosciences Research Foundation

Conditions:

Polyneuropathies

Eligibility:

All Genders

Brief Summary

This Individual Patient Expanded Access IND has been created as requested by an 58-year-old man who suffers from Polyneuropathy due to Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopat...

Detailed Description

A screening visit will be conducted to assess the eligibility for this investigation. If the participant qualifies the expanded access program eligibility requirements, he will be treated with the inv...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Patient diagnosed with Polyneuropathy due to POEMS Syndrome.
  • Patient must have banked his stem cells at Hope Biosciences LLC.
  • Exclusion Criteria
  • The patient has any active infection requiring medications.
  • The patient has any suicidal ideation during the screening visit.

Exclusion

    Key Trial Info

    Start Date :

    Trial Type :

    EXPANDED_ACCESS

    End Date :

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT04064983

    Last Update

    September 29 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hope Biosciences Stem Cell Research Foundation

    Sugar Land, Texas, United States, 77478